AdvaMed Submits Comments on FY 2023 IPPS Proposed Rule
AdvaMed submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.
Learn more about our Payment & Health Care Delivery Policy work.
AdvaMed submitted comments to CMS on the Fiscal Year 2023 Hospital Inpatient Prospective Payment System proposed rule.
AdvaMed submitted comments to the Center for Medicare and Medicaid Services (CMS) on its Radiation Oncology (RO) Model proposed rule proposing to indefinitely delay the start date of the RO…
AdvaMed launched a Strategic Value Initiative to develop an approach and principles for assessing the value of medical technologies that can be adopted by health systems, payers, medtech companies, and…
AdvaMed develops and advocates for sound payment policies that promote equitable patient access to diagnostic tests.
AdvaMed develops strategies for improving Medicare coverage and payment systems and methodologies impacting patients, providers, and suppliers.
AdvaMed submitted a letter regarding proposed local coverage determinations entitled “Skin Substitutes for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcer.”
AdvaMed urged CDC to recognize the critical role evidence-based and FDA-approved/cleared devices can and should play in improving pain management and reducing opioid-related harms.
During two listening sessions, AdvaMed provided responses to a set of questions posed by CMS on the parameters for a new TCET program, including the types of guidance provided by…
AdvaMed submitted a response to a Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) Request for Information (RFI) on electronic prior…
AdvaMed submitted a response to a White House Office of Science and Technology Policy (OSTP) Request for Information (RFI) on Strengthening Community Health Through Technology.